NCT00050986 2020-09-22
Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
M.D. Anderson Cancer Center
Phase 1/2 Completed
Clinical Trials
16 trialsNCT00077519 2020-04-15
Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00004009 2019-11-07
R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
University of Maryland, Baltimore
Phase 1 Completed
NCT00025480 2019-03-13
Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00005859 2018-06-26
Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT00047216 2015-07-23
Tipifarnib in Treating Patients With Recurrent Bladder Cancer
University Health Network, Toronto
Phase 2 Completed
NCT00101153 2015-07-23
Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
University Health Network, Toronto
Phase 1 Completed
NCT00972712 2015-03-10
Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma
Emory University
Phase 1 Completed
NCT00005848 2013-07-11
R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Fox Chase Cancer Center
Phase 2 Completed
NCT00005041 2012-11-09
R115777 in Treating Patients With Relapsed Small Cell Lung Cancer
NYU Langone Health
Phase 2 Completed
NCT00005990 2012-11-09
R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors
NYU Langone Health
Phase 1 Completed
NCT00012350 2012-10-23
Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT00040105 2012-08-01
Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00003707 2012-06-28
Combination Chemotherapy in Treating Patients With Advanced Cancer
The University of Texas Health Science Center at San Antonio
Phase 1 Completed
NCT00005989 2011-08-04
R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer
Mayo Clinic
Phase 2 Completed
NCT00025454 2010-02-08
R115777 in Treating Patients With Advanced Solid Tumors
City of Hope Medical Center
Phase 1 Completed